COVID 19 Spike RBD Coronavirus Recombinant Antibody | COVID-19 recombinant antibody
SARS-CoV-2 Spike RBD Nanobody, FITC conjugated
Reactivity
Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
Applications
ELISA
Purity
Affinity-chromatography
Synonyms
COVID 19 Spike RBD Coronavirus, Recombinant Antibody; SARS-CoV-2 Spike RBD Nanobody, FITC conjugated; 2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Spike RBD; COVID-19 recombinant antibody
Reactivity
Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
Clonality
Monoclonal
Isotype
VHH fusion with human IgG1 Fc
Clone Number
A1
Purity/Purification
Affinity-chromatography
Form/Format
Liquid
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH7.4
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH7.4
Applicable Applications for COVID-19 recombinant antibody
ELISA
Antibody Type
Recombinant Antibody
Conjugate
FITC
Immunogen
Recombinant Human Novel Coronavirus Spike glycoprotein(S) (319-541aa) ( and )
Immunogen Species
Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
Abbreviation
S
Research Area
Microbiology
Preparation and Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Related Product Information for COVID-19 recombinant antibody
The production of the SARS-CoV-2 Spike RBD recombinant monoclonal antibody is a complex process that requires multiple steps. Firstly, the SARS-CoV-2 Spike RBD monoclonal antibody is collected and its gene sequence is analyzed. Following that, a vector containing the SARS-CoV-2 Spike RBD monoclonal antibody gene is constructed and transfected into a host cell line for culturing. To create the SARS-CoV-2 Spike RBD monoclonal antibody, a recombinant human SARS-CoV-2 Spike glycoprotein (S) (319-541aa) (MBS7135911 and MBS9018425) is used as an immunogen. The SARS-CoV-2 Spike RBD recombinant monoclonal antibody is then purified via affinity chromatography and its specificity is verified through ELISA. It is conjugated with a FITC tag.
The SARS-CoV-2 spike RBD plays a critical role in the virus's ability to infect human cells. The RBD binds to the human cell surface receptor ACE2, which is expressed on the surface of cells in various tissues, including the lungs, heart, kidneys, and intestines. This interaction triggers the fusion of the virus and the host cell, allowing the virus to enter the cell and initiate the infection process. Once inside the host cell, the virus uses its own genetic material to hijack the host cell's machinery to replicate and spread. Mutations in the RBD can affect its ability to bind to ACE2, impacting the virus's infectivity and virulence.
The SARS-CoV-2 spike RBD plays a critical role in the virus's ability to infect human cells. The RBD binds to the human cell surface receptor ACE2, which is expressed on the surface of cells in various tissues, including the lungs, heart, kidneys, and intestines. This interaction triggers the fusion of the virus and the host cell, allowing the virus to enter the cell and initiate the infection process. Once inside the host cell, the virus uses its own genetic material to hijack the host cell's machinery to replicate and spread. Mutations in the RBD can affect its ability to bind to ACE2, impacting the virus's infectivity and virulence.
Product Categories/Family for COVID-19 recombinant antibody
NCBI and Uniprot Product Information
UniProt Accession #
Similar Products
Product Notes
The COVID-19 (Catalog #AAA243905) is a Recombinant Antibody and is intended for research purposes only. The product is available for immediate purchase. The SARS-CoV-2 Spike RBD Nanobody, FITC conjugated reacts with Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) and may cross-react with other species as described in the data sheet. AAA Biotech's COVID 19 Spike RBD Coronavirus can be used in a range of immunoassay formats including, but not limited to, ELISA. Researchers should empirically determine the suitability of the COVID-19 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "COVID 19 Spike RBD Coronavirus, Monoclonal Recombinant Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.